Amy Winehouse can’t wait to get back to work

London, Sept 18: Brit jazz star Amy Winehouse is all set to make a comeback after seemingly sorting out her drug and alcohol woes.

The 24-year-old, who has been through a tumultuous period of drug abuse, has insisted that ‘nothing is wrong with her’.

Winehouse also credited her friends for her speedy recovery.

 "A lot of fuss has been made about nothing. There's nothing wrong with me. "In fact, I feel better than I've ever felt before. I'm sorted out,’ the Mirror quoted her, as saying.

Troop movements in Iraq damaging its historic past

London, Sept.17: The massive movements of troops through battle-scarred Iraq is damaging that country’s valuable historic past, a report in The Independent has claimed.

The near total destruction of Iraq's historic past – the very cradle of human civilisation – has emerged as one of the most shameful symbols of the U.S.-led operation, say archaeologists.

Jamelia hopes to rekindle romance with ex Darren Byfield

London, Sept 17 (ANI): Singer Jamelia has revealed that she hopes to rekindle her romance with her footballer ex Darren Byfield.

The 26-year-old star, who split from the footballer last month after romancing for three years, said that she is hoping to get back together with Byfield.

“It would be nice to have a reconciliation with Darren but we will see,” Sun quoted Jamelia, as saying.

Jamelia, a mum of two, rubbished off reports saying they broke up because Darren cheated on her.

Early death risk not enough to make Brits exercise: Survey

London, Sept 17: A survey has revealed that even the threat of an early death due to lack of physical activity is not enough to make Brit adults exercise.

The survey conducted by YouGov revealed that only 38 percent of people questioned were willing to exercise more if their life is depended on it.

Experts also said that people with a healthy weight should also workout in order to avoid health problems later in life.

Drug that kills cancer cells developed

London, Sept 17: A drug, called STA-4783, has been developed to kill cancer cells. Unlike current treatments, the drug has very few side-effects, and those who have started taking the drug have already doubled their life expectancy, with researchers believing that survival rates could be even higher.

“This is the most exciting cancer treatment I’ve seen in 10 years,” Daily Express quoted cancer specialist Dr Tony Williams of Synta Pharmaceuticals, who is developing the drug, as saying.

Kelly Brook to flaunt ‘all her best bits’ on ‘Strictly Come Dancing’

London, Sept 17: Model Kelly Brook is gearing up to appear almost nude on BBC One hit show ‘Strictly Come Dancing’, for she will wear a skimpy flesh-coloured leotard for one of the episodes of the series.

A source of the show, which starts next month, said that the saucy costume was designed exclusively to show the busty model’s curves.

“Kelly’s got an amazing figure — the dress designer was very keen to show it off, Sun quoted the source, as saying.

“She will be flaunting all her best bits on camera,” source added.

Pages

News in Focus

Cerebras Systems Prepares for IPO; Nvidia, Oracle Support the Chipmaker

Cerebras Systems is poised to file for an IPO, signaling a pivotal moment in the rapidly evolving AI chip landscape.

Agentic AI Privacy Concerns Rise as AI Platforms Offer Tasks Based on User Preferences

Agentic AI marks a profound shift from passive digital assistance to autonomous execution, bringing with it a new frontier of privacy risks.

Nvidia (NVDA) Stock Price Could Reach $300 as per Bernstein’s David Dai; Nasdaq Composite at Record Highs

Nvidia continues to command the narrative in global technology markets, with Bernstein reaffirming its bullish stance and projecting a $300 price target, anchored by the transformative potential o

Nasdaq Composite Closes at All-Time Highs; Nvidia Stock Price Above $200, Tesla Closes 3% Higher

Nasdaq Composite Closed at all-time highs as investors turned bullish on Iran-US talks to end the war.

HDFC AMC Share Price Target at Rs 3,063: Deven Choksey Research

Deven Choksey Research has reiterated an ACCUMULATE stance on HDFC Asset Management Company, highlighting that the recent earnings miss is largely optical and driven by one-off treasury adjustments